SCHEMBL19934176

SCHEMBL19934176

NC1Cc2c(Cl)cccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AADAT Q8N5Z0 2/20 0.50
TRPM5 Q9NZQ8 1/20 0.41
KDM1A O60341 1/20 0.41
DPP4 P27487 2/20 0.40
HTR2C P28335 4/20 0.40
HTR2A P28223 3/20 0.38
HTR2B P41595 2/20 0.38
TP53 P04637 1/20 0.37
RECQL P46063 1/20 0.37
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
HTR1A P08908 1/20 0.34
HTR1D P28221 1/20 0.34
HTR7 P34969 1/20 0.34
HTR3A P46098 1/20 0.34
HTR5A P47898 1/20 0.34
NOTUM Q6P988 1/20 0.34
ADRA2A P08913 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL19925523 0.98 AADAT (0.49) AADATTRPM5KDM1ADPP4HTR2C
SCHEMBL193872 0.79 HTR2C (0.45) AADATKDM1ADPP4HTR2CHTR2A
SCHEMBL193435 0.79 HTR2C (0.45) AADATKDM1ADPP4HTR2CHTR2A
SCHEMBL193434 0.79 HTR2C (0.45) AADATKDM1ADPP4HTR2CHTR2A
SCHEMBL31250078 0.79 HTR2C (0.45) AADATKDM1ADPP4HTR2CHTR2A
SCHEMBL30229855 0.79 HTR2C (0.45) AADATKDM1ADPP4HTR2CHTR2A
Hydrochloric Acid SCHEMBL11574629 0.78 ACHE (0.47) AADATKDM1ADPP4HTR2CHTR2A
Hydrochloric Acid SCHEMBL31186922 0.78 ACHE (0.47) AADATKDM1ADPP4HTR2CHTR2A
SCHEMBL23871719 0.76 HTR2C (0.42) AADATTRPM5KDM1ADPP4HTR2C
SCHEMBL10320766 0.76 AADAT (0.41) AADATTRPM5KDM1ADPP4HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504185-B1 NOVEL SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS MERCK SHARP & DOHME (US) 2021-11-24 EP disclosed
US-10988487-B2 Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors MERCK SHARP & DOHME CORP. (US) 2021-04-27 US disclosed
US-20200231606-A1 NOVEL SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-07-23 US disclosed
WO-2018044663-A1 NOVEL SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10988487-B2 Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors IDO1, IDO2, INMT AADAT 8/4885TRPM5 2021/4885KDM1A 386/4885
US-20200231606-A1 NOVEL SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS IDO1, IDO2, INMT AADAT 8/4885TRPM5 1930/4885KDM1A 302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.